Physician profile
Mark A Oatman
NPI 1205814449
$2,671.28
in general payments reported to CMS, 2019-2025
20 companies · $799 in 2025
The $799 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.38 · 2020: $20.13 · 2021: $223 · 2022: $136 · 2023: $1,036 · 2024: $399 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269 · Consulting Fee: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.40 |
| Consulting Fee | $965.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 110 LLC | $965.00 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $477.30 | 2019-2025 | Xtampza, Belbuca |
| Forte Bio-Pharma LLC | $285.59 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.62 | 2021-2025 | Relistor |
| Si-Bone, INC. | $145.36 | 2025 | |
| Grt US Holding, INC. | $144.16 | 2021 | |
| Lilly USA, LLC | $79.67 | 2022-2023 | Reyvow, Emgality |
| Appliedvr INC | $52.86 | 2025 | Relievrx |
| Saluda Medical Americas, INC. | $44.62 | 2025 | Evoke |
| Averitas Pharma INC. | $42.06 | 2024-2025 | Qutenza |
| Medtronic, INC. | $32.89 | 2021-2022 | |
| Valinor Pharma, LLC | $31.95 | 2025 | Movantik |
| Scilex Pharmaceuticals INC. | $30.69 | 2022-2023 | Ztlido |
| Amneal Pharmaceuticals LLC | $20.83 | 2023 | Lyvispah |
| Biogen, INC. | $20.54 | 2025 | Skyclarys |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $20.13 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.41 | 2025 | |
| Exact Sciences Corporation | $15.25 | 2023 | Cologuard Collection Kit |
| Sentynl Therapeutics, INC. | $13.98 | 2019 | |
| Biodelivery Sciences International, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.